Difficulties in diagnosing neuropsychiatric complications of corticosteroids in advanced cancer patients: Two case reports

Journal of Pain and Symptom Management

Volumn 19, Issue 4, 2000, Pages 309-317

  Jenkins, Catherine A ^a   Bruera, Eduardo ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer patients; Corticosteroids; Neuropsychological complications

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HALOPERIDOL; LORAZEPAM; PAROXETINE; RISPERIDONE;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN EDEMA; CASE REPORT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; FEMALE; HALLUCINATION; HUMAN; INTESTINE OBSTRUCTION; KIDNEY CARCINOMA; MALE; MALIGNANT MENINGIOMA; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; NAUSEA; NEUROPSYCHIATRY; PALLIATIVE THERAPY; VISUAL HALLUCINATION;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MENINGIOMA; MENTAL DISORDERS; MIDDLE AGED; NEOPLASMS;

EID: 0034009125     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00116-0     Document Type: Article

References (55)

1. Minagawa H., Uchitomi Y., Yamawaki S., Ishitani K. Psychiatric morbidity in terminally ill cancer patients. a prospective study Cancer. 78:1996;1131-1137.
2. Chochinov H.M., Wilson K.G., Enns M., Lander S. Prevalence of depression in the terminally ill. effects of diagnostic criteria and symptom threshold judgments Am J Psych. 151:1994;537-540.
3. Periera J., Hanson J., Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 79:1997;835-842.
4. Bruera E., Franco J.J., Maltoni M., Watanabe S., Suarez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer. association with cognitive monitoring, hydration and opiate rotation J Pain Symptom Manage. 10:1995;287-291.
5. de Stoutz N.D., Bruera E., Suarez-Almazor M. Opioid rotation (OR) for toxicity reduction in terminal cancer patients. J Pain Symptom Manage. 10:1995;378-384.
6. Fainsinger RL, Bruera E, Watanabe S. Commonly prescribed medications in advanced cancer patients. Presented at the Seventh Annual Palliative Care Conference: Education and Research Days. Fantasyland Hotel, Edmonton, AB, Oct. 19-20, 1995.
7. Stiefel F.R., Breitbart W.S., Holland J.C. Corticosteroids in cancer. neuropsychiatric complications Cancer Investiga. 7:1989;479-491.
8. Alpert E., Seigerman C. Steroid withdrawal psychosis in a patient with closed head injury. Arch Phys Med Rehabil. 67:1986;766-769.
9. Hall R.C.W., Popkin M.K., Stickney S.K., Gardner E.R. Presentation of the steroid psychoses. J Nerv Mental Dis. 167:1979;229-236.
10. Pereira J, Bruera E. Chronic nausea. In: Bruera E, Higginson I, eds. Cachexia anorexia in cancer patients. Oxford: Oxford University Press, 1996;2:23-37.
11. Watanabe S., Bruera E. Corticosteroids as adjuvant analgesics. J Pain Symptom Manage. 9:1994;442-445.
12. Gutlin P.H. Corticosteroid therapy in patients with cerebral tumors. benefits, mechanisms, problems, practicalities Semin Oncol. 2:1975;49-55.
13. Fainsinger R.L., Spachynski K., Hanson J., Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction. J Pain Symptom Manage. 9:1994;12-18.
14. Smith P., Bruera E. Case Report. management of malignant ureteral obstruction in the palliative care setting J Pain Symptom Manage. 10:1995;401-404.
15. Folstein M.F., Folstein S., McHugh P.R. "Mini-mental state" a practical method for grading the cognitive state of patients for the clinician J Psych Res. 12:1975;189-198.
16. Weissman D.E. Glucocorticoid treatment for brain metastases and epidural spinal cord compression. a review J Clin Oncol. 6:1988;543-551.
17. Bruera E., Roca E., Cedaro L., Carraro S., Chacon R. Action of oral methylprednisolone in terminal cancer patients. a prospective randomized double-blind study Cancer Treat Rep. 69:1985;751-754.
18. Loprinzi C.L. Management of cancer anorexia/cachexia. Support Care Cancer. 3:1995;120-122.
19. Gagnon B., Bruera E. A review of the drug treatment of cachexia associated with cancer. Drugs. 55:1998;675-688.
20. Brietbart W., Stiefel F., Kornblith A.B., Pannullo S. Neuropsychiatric disturbance in cancer patients with epidural spinal cord compression receiving high dose corticosteroids. a prospective comparison study Psycho-oncology. 2:1993;233-245.
21. Rome H., Braceland F. The psychological response to ACTH, cortisone, hydrocortisone and related steroid substances. Am J Psychiatry. 108:1952;641-651.
22. Bruera E., Roca E., Cedaro L., Carraro S., Chacon R. Action of oral methyprednisolone in terminal cancer patients. a prospective randomized double-blind study Cancer Treat Rep. 69:1985;751-754.
23. Black A.S. Biochemical mechanisms of steroid-induced psychosis. N Y State J Med. 82:1982;1024-1028.
24. Peretti S., Di Giannuario A., Domenici M.R., Sagratella S., Capasco A., Sorrentino K., Loizza A. Dexamethasone-induced selective inhibition of the central mu opioid receptor. functional and in vivo and in vitro evidence in rodents Br J Pharmacol. 113:1994;1416-1422.
25. Sapolsky R.M. Glucocorticoids, hippocampal damage and the glutamatergic synapse. Prog Brain Res. 86:1990;13-23.
26. Majewska M.K. Steroids and brain activity. essential dialogue between body and mind Biochem Pharmacol. 36:1987;3781-3788.
27. Chaouloff F. Regulation of 5-HT receptors by corticosteroids. where do we stand? Fundam Clin Pharmacol. 9:1995;219-233.
28. Meijer O.C., de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus. functional implications of central corticosteroid receptor diversity Crit Neurobiol. 12:1998;1-20.
29. Itil T.M., Herrman W.M. Effects of hormones on computer analyzed human electroencephalogram. Lipton M.A., DiMascio A., Killiam K.F. Psychopharmacology. a generation of progress:1978;729 Raven Press, New York.
30. Bruera E., Watanabe S. Psychostimulants as adjuvant analgesics. J Pain Symptom Manage. 9:1994;412-415.
31. Murphy B.E. Steroids and depression. J Steroid Biochem Mol Biol. 38:1991;537-559.
32. Arana G.W., Santos A.B., Laraia M.T., McLeod-Bryant S., Beale M.D., Rames L.J., Roberts J.M., Dias J.K., Mollow M. Dexamethasone for the treatment of depression. a randomized, placebo-controlled, double blind trial Am J Psychiatry. 152:1995;265-267.
33. Klein J.F. Adverse psychiatric effects of systemic glucocorticoid therapy. Am Fam Physician. 46:1992;1469-1474.
34. Ling M.H., Perry P.J., Tusang M.T. Side effects of corticosteroid therapy. psychiatric aspects Arch Gen Psychiatry. 38:1981;471-477.
35. Lupien S.J., McEwan B.S. The acute effects of corticosteroids on cognition. integration of animal and human model studies Brain Res Rev. 24:1997;1-27.
36. Wolkowitz O.W., Reus V.I., Weingartner H., Thompson K., Breier A., Doran A., Rubinow D., Pickar D. Cognitive effects of corticosteroids. Am J Psychiatry. 147:1990;1297-1303.
37. Landfield P.W. Nathan Shock Memorial Lecture 1990. The role of glucocorticoids in brain aging and Alzheimer's disease. an integrative physiological hypothesis Exper Gerontol. 29:1994;3-11.
38. Uno H., Eisele S., Sakai A., Shelton S., Baker E., DeJesus O., Holden J. Neurotoxicity of glucocorticoids in the primate brain. Hormones Behavior. 28:1994;336-348.
39. McLay R.N., Freeman S.M., Harlan R.E., Ide C.F., Kastin A.J., Zadina J.E. Aging in the hippocampus. interrelated actions of neurotropins and glucocorticoids Neurosci Biobehavior Rev. 21:1997;615-629.
40. Roberts A.J., Keith L.D. Corticosteroids enhance convulsion susceptibility via central mineralocorticoid receptors. Psychoneuroendocrinology. 20:1995;891-902.
41. Schimmer B.P., Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. Hardman J.G., Limbird L.E. Goodman and Gilman's The pharmacological basis of therapeutics. 9th ed:1996;1459-1485 McGraw-Hill, New York.
42. Lipowski Z.J. Delirium and impaired consciousness. Evans J.G., Williams T.F. Oxford textbook of geriatric medicine. 1992;490-495 Oxford University Press, Oxford.
43. Bruera E., Chadwick S., Brenneis C. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep. 71:1987;120-127.
44. Bruera E., Macmillan K., Hanson J., Kuehn N., MacDonald R.N. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer. 66:1990;1279-1282.
45. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 13:1972;694-698.
46. Vecht C.J., Hovestadt A., Verbiest H.B., van Vliet J.J., van Putten W.L. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors. a randomized study of doses of 4, 8, and 16 mg per day Neurology. 44:1994;675-680.
47. Vecht C.J., Haaxma-Reiche H., van Putten W.L.J., Visser M., Vries E.P., Twijnstra A. Initial bolus of conventional versus high dose dexamethasone in metastatic spinal cord compression. Neurology. 39:1989;1255-1257.
48. Breitbart W., Wein S.E. Metabolic disorders and neuropsychiatric symptoms. Holland J.C. Psycho-oncology. 1998;639-649 Oxford University Press, New York, Oxford.
49. Falk W.E., Mahnke M.W., Poskanzer D.C. Lithium prophylaxis of corticotropin-induced psychosis. JAMA. 241:1979;1011-1012.
50. Terao T., Mizuki T., Ohji T., Abe K. Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction treated with corticosteroid. Br J Psych. 164:1994;109-111.
51. Baldessarini R.J. Drugs and the treatment of psychiatric disorders. depression and mania Hardman J.G., Limbird L.E. Goodman and Gilman's The pharmacological basis of therapeutics. 9th ed:1996;431-459 McGraw Hill, New York.
52. Lynn D.J. Lithium in steroid-induced depression. Br J Psych. 166:1995;264.
53. McNamara J.O. Drugs effective in the treatment of the epilepsies. Hardman J.G., Limbird L.E. Goodman and Gilman's The pharmacological basis of therapeutics. 9th ed:1996;461-486 McGraw-Hill, New York.
54. Bruera E., Chadwick S., MacDonald N., Fox R., Hanson J. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep. 70:1986;1383-1387.
55. Baldessarini R.J. Drugs and the treatment of psychiatric disorders. psychosis and anxiety Hardman J.G., Limbird L.E. Goodman and Gilman's The pharmacological basis of therapeutics. 9th ed:1996;399-430 McGraw-Hill, New York.